| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |